169 related articles for article (PubMed ID: 23737345)
1. Ocular disposition of the hemiglutarate ester prodrug of ∆⁹-Tetrahydrocannabinol from various ophthalmic formulations.
Hingorani T; Adelli GR; Punyamurthula N; Gul W; Elsohly MA; Repka MA; Majumdar S
Pharm Res; 2013 Aug; 30(8):2146-56. PubMed ID: 23737345
[TBL] [Abstract][Full Text] [Related]
2. Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability.
Adelli GR; Bhagav P; Taskar P; Hingorani T; Pettaway S; Gul W; ElSohly MA; Repka MA; Majumdar S
Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2167-2179. PubMed ID: 28399267
[TBL] [Abstract][Full Text] [Related]
3. Effect of ion pairing on in vitro transcorneal permeability of a Δ(9) -tetrahydrocannabinol prodrug: potential in glaucoma therapy.
Hingorani T; Gul W; Elsohly M; Repka MA; Majumdar S
J Pharm Sci; 2012 Feb; 101(2):616-26. PubMed ID: 21989812
[TBL] [Abstract][Full Text] [Related]
4. Ocular Disposition of ∆
Punyamurthula NS; Adelli GR; Gul W; Repka MA; ElSohly MA; Majumdar S
AAPS PharmSciTech; 2017 Aug; 18(6):1936-1945. PubMed ID: 27905004
[TBL] [Abstract][Full Text] [Related]
5. Enhanced solubility, stability, and transcorneal permeability of δ-8-tetrahydrocannabinol in the presence of cyclodextrins.
Hippalgaonkar K; Gul W; ElSohly MA; Repka MA; Majumdar S
AAPS PharmSciTech; 2011 Jun; 12(2):723-31. PubMed ID: 21637944
[TBL] [Abstract][Full Text] [Related]
6. Chemical stability and bioadhesive properties of an ester prodrug of Delta 9-tetrahydrocannabinol in poly(ethylene oxide) matrices: effect of formulation additives.
Thumma S; Majumdar S; ElSohly MA; Gul W; Repka MA
Int J Pharm; 2008 Oct; 362(1-2):126-32. PubMed ID: 18652884
[TBL] [Abstract][Full Text] [Related]
7. Preformulation studies of a prodrug of Delta9-tetrahydrocannabinol.
Thumma S; Majumdar S; Elsohly MA; Gul W; Repka MA
AAPS PharmSciTech; 2008; 9(3):982-90. PubMed ID: 18756377
[TBL] [Abstract][Full Text] [Related]
8. Influence of plasticizers on the stability and release of a prodrug of Delta(9)-tetrahydrocannabinol incorporated in poly (ethylene oxide) matrices.
Thumma S; ElSohly MA; Zhang SQ; Gul W; Repka MA
Eur J Pharm Biopharm; 2008 Oct; 70(2):605-14. PubMed ID: 18602993
[TBL] [Abstract][Full Text] [Related]
9. Effect of surfactant concentration and sterilization process on intraocular pressure-lowering activity of Δ
Sweeney C; Dudhipala N; Thakkar R; Mehraj T; Marathe S; Gul W; ElSohly MA; Murphy B; Majumdar S
Drug Deliv Transl Res; 2021 Oct; 11(5):2096-2107. PubMed ID: 33169348
[TBL] [Abstract][Full Text] [Related]
10. Is 2-Hydroxypropyl-β-cyclodextrin a Suitable Carrier for Central Administration of Δ
Agabio R; Sanna F; Lobina C; Monduzzi M; Nairi V; Cugia F; Mameli S; Pisanu GM; Gessa GL; Melis MR
Drug Dev Res; 2017 Dec; 78(8):411-419. PubMed ID: 28921601
[TBL] [Abstract][Full Text] [Related]
11. Transporter targeted gatifloxacin prodrugs: synthesis, permeability, and topical ocular delivery.
Vooturi SK; Kadam RS; Kompella UB
Mol Pharm; 2012 Nov; 9(11):3136-46. PubMed ID: 23003105
[TBL] [Abstract][Full Text] [Related]
12. Ocular drug metabolism of the bioactivating antioxidant N-acetylcarnosine for vision in ophthalmic prodrug and codrug design and delivery.
Babizhayev MA
Drug Dev Ind Pharm; 2008 Oct; 34(10):1071-89. PubMed ID: 18777243
[TBL] [Abstract][Full Text] [Related]
13. In vivo characterisation of a novel water-soluble Cyclosporine A prodrug for the treatment of dry eye disease.
Rodriguez-Aller M; Kaufmann B; Guillarme D; Stella C; Furrer P; Rudaz S; El Zaoui I; Valamanesh F; Di Tommaso C; Behar-Cohen F; Veuthey JL; Gurny R
Eur J Pharm Biopharm; 2012 Apr; 80(3):544-52. PubMed ID: 22155591
[TBL] [Abstract][Full Text] [Related]
14. Topical delivery of aqueous micellar resolvin E1 analog (RX-10045).
Cholkar K; Gilger BC; Mitra AK
Int J Pharm; 2016 Feb; 498(1-2):326-34. PubMed ID: 26706439
[TBL] [Abstract][Full Text] [Related]
15. Rectal bioavailability of delta-9-tetrahydrocannabinol from the hemisuccinate ester in monkeys.
ElSohly MA; Stanford DF; Harland EC; Hikal AH; Walker LA; Little TL; Rider JN; Jones AB
J Pharm Sci; 1991 Oct; 80(10):942-5. PubMed ID: 1664466
[TBL] [Abstract][Full Text] [Related]
16. Diclofenac sodium ion exchange resin complex loaded melt cast films for sustained release ocular delivery.
Adelli GR; Balguri SP; Bhagav P; Raman V; Majumdar S
Drug Deliv; 2017 Nov; 24(1):370-379. PubMed ID: 28165833
[TBL] [Abstract][Full Text] [Related]
17. New micelle myricetin formulation for ocular delivery: improved stability, solubility, and ocular anti-inflammatory treatment.
Sun F; Zheng Z; Lan J; Li X; Li M; Song K; Wu X
Drug Deliv; 2019 Dec; 26(1):575-585. PubMed ID: 31172843
[TBL] [Abstract][Full Text] [Related]
18. In-vitro hydrolysis, permeability, and ocular uptake of prodrugs of N-[4-(benzoylamino)phenylsulfonyl]glycine, a novel aldose reductase inhibitor.
Sunkara G; Deruiter J; Clark CR; Kompella UB
J Pharm Pharmacol; 2000 Sep; 52(9):1113-22. PubMed ID: 11045892
[TBL] [Abstract][Full Text] [Related]
19. A submicron emulsion as ocular vehicle for delta-8-tetrahydrocannabinol: effect on intraocular pressure in rabbits.
Muchtar S; Almog S; Torracca MT; Saettone MF; Benita S
Ophthalmic Res; 1992; 24(3):142-9. PubMed ID: 1328979
[TBL] [Abstract][Full Text] [Related]
20. In vivo distribution and ex vivo permeation of cyclosporine A prodrug aqueous formulations for ocular application.
Rodriguez-Aller M; Guillarme D; El Sanharawi M; Behar-Cohen F; Veuthey JL; Gurny R
J Control Release; 2013 Aug; 170(1):153-9. PubMed ID: 23648835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
